NANETTE MAMEDOV: Open Payments
NPI 1306311717 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,823 in 98 payments from 15 companies in 2025. Trend: 2023 $1,438 · 2024 $1,562 · 2025 $1,823
Food & beverage: $1,823
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $570 |
| Janssen Biotech, Inc. | 19 | $326 |
| Madrigal Pharmaceuticals | 15 | $196 |
| PFIZER INC. | 6 | $114 |
| Aimmune Therapeutics, Inc. | 4 | $111 |
| Phathom Pharmaceuticals, Inc. | 5 | $103 |
| Ardelyx, Inc. | 4 | $86 |
| Gilead Sciences, Inc. | 4 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Novo Nordisk Inc | 2 | $51 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, SKYRIZI, ZENPEP, VOQUEZNA, CREON, IBSRELA.
Industry payments across MD — which companies pay providers there.
